Veterinary Medicines

KARIMULINA 101,2 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR RABBITS

Authorised
  • Tiamulin hydrogen fumarate
Download as PDF

Product identification

Medicine name:
KARIMULINA 101,2 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR RABBITS
Karimulina 101,2 mg/ml soluzione orale per uso in acqua da bere per conigli
Active substance:
  • Tiamulin hydrogen fumarate
Target species:
  • Rabbit
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tiamulin hydrogen fumarate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Rabbit
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • White high-density polyethylene barrel of 5-L capacity
  • White high-density polyethylene bottle of 1-L capacity

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105707
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0456/001
Concerned member states:
  • Italy
  • Portugal
  • Spain
Generic of:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 29/05/2024
Updated on: 30/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."